Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
子宮内膜症の治療のためのミネラルコルチコイド受容体アンタゴニスト
Document Type and Number:
Japanese Patent JP2010520178
Kind Code:
A
Abstract:
The mineralcorticoid receptor antagonist comprises spironolactone, eplerenone and drospirenone. Glucocorticoid, progesterone receptor antagonist and estrogen receptor antagonist are also included. The estrogen is ethinylestradiol. ACTIVITY : Gynecological. MECHANISM OF ACTION : Mineralcorticoid receptor antagonist; Gonadotropin-releasing hormone (GnRH) agonist.

Inventors:
Mellar, Karsten
Kaufmann-Reihe, Ulrike
Schmidt, Anya
Furman, Ulrike
Fisher, Oliver-Martin
Application Number:
JP2009551220A
Publication Date:
June 10, 2010
Filing Date:
February 28, 2008
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Bayer Schering Pharma Aktiengesellschaft
International Classes:
A61K31/585; A61K31/565; A61K31/57; A61K45/00; A61P15/00; A61P43/00; C07J21/00
Domestic Patent References:
JP2003520239A2003-07-02
Other References:
JPN5010006878; SAWADA T: CLINICAL GYNECOLOGY AND OBSTETRICS V45 N1, 1991, P111-114
JPN5010006876; DICKEY R P: FERTILITY AND STERILITY V42 N5, 198411, P709-716
JPN6012067280; 東海産科婦人科学会雑誌 vol.34, 1997, p.25-30
Attorney, Agent or Firm:
Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Yoichi Watanabe
Kazuhiro Nakamura
Tatsunori Ikeda